• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

NOSIUM

2.99 SEK

+8.73 %

Less than 1K followers

NOSIUM B

NGM Growth Market

Investment

Financials

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+8.73 %
+11.15 %
+10.74 %
-8.28 %
+9.12 %
-31.42 %
-95.36 %
-97.77 %
-98.15 %

NOSIUM is a venture builder that invests in entrepreneurs and develops companies within consumer products and lifestyle. The company owns, manages and acquires shares in companies with the goal of increasing their growth and market value by providing strategic and operational assistance. NOSIUM was founded in 1994 and is headquartered in Stockholm, Sweden.

Read more
Market cap
10.24M SEK
Turnover
5.29K SEK
Revenue
4.98M
EBIT %
-117.87 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26/6
2026

General meeting '26

28/6
2026

General meeting '26

28/8
2026

Interim report Q2'26

Regulatory press release6/5/2026, 2:30 PM

RÄTTELSE: NOSIUM AB (publ) publicerar komplett årsredovisning för 2025 inklusive revisionsberättelse

NOSIUM
Regulatory press release6/5/2026, 12:00 PM

NOSIUM AB (publ) publicerar årsredovisning för 2025 och uppdaterar kring processen med Medicortex

NOSIUM
Regulatory press release6/2/2026, 6:30 AM

KALLELSE TILL ÅRSSTÄMMA I NOSIUM AB (PUBL)

NOSIUM

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/28/2026, 1:00 PM

NOSIUM AB (publ) offentliggör delårsrapport för perioden januari–mars för 2026

NOSIUM
Regulatory press release5/28/2026, 12:50 PM

NOSIUM AB (publ) informerar om nedskrivning av Dr Sannas Sweden AB och uppdaterar tidplan för årsredovisning

NOSIUM
Regulatory press release5/27/2026, 9:12 AM

NOSIUM UPPMÄRKSAMMAR: BREV FRÅN MEDICORTEX STYRELSEORDFÖRANDE TILL AKTIEÄGARNA

NOSIUM
Regulatory press release5/22/2026, 7:21 AM

NOSIUM UPPMÄRKSAMMAR: MEDICORTEX FÅR FÖRLÄNGNING AV DoD-PROJEKT

NOSIUM
Regulatory press release4/28/2026, 10:00 AM

NOSIUM AB (publ) – Extra bolagsstämma den 28 april 2026

NOSIUM
Regulatory press release4/27/2026, 8:49 AM

NOSIUM AB (publ) ingår avtal om försäljning av Dr Sannas Sweden AB

NOSIUM
Regulatory press release3/31/2026, 6:00 AM

KALLELSE TILL EXTRA BOLAGSSTÄMMA I NOSIUM AB (PUBL)

NOSIUM
Regulatory press release3/13/2026, 2:20 PM

NOSIUM SÄKERSTÄLLER KAPITALBAS GENOM FINANSIERING OM 4 MSEK

NOSIUM
Regulatory press release2/20/2026, 1:00 PM

NOSIUM AB (publ) offentliggör bokslutskommuniké för 2025

NOSIUM
Regulatory press release12/29/2025, 7:30 AM

MEDICORTEX LÄMNAR IN ANSÖKAN TILL NGM & UPPNÅR 89,9 PROCENT AKTIEÄGARANSLUTNING

NOSIUM
Regulatory press release12/12/2025, 11:55 AM

MEDICORTEX BEVILJAS EUROPEISKT PATENT – STÄRKER SKYDDET FÖR UNIK TBI-DIAGNOSTIK

NOSIUM
Regulatory press release12/8/2025, 11:06 AM

AKTIEÄGARE REPRESENTERANDE ÖVER 80 PROCENT I MEDICORTEX ANSLUTER TILL FÖRVÄRVET

NOSIUM
Regulatory press release11/27/2025, 8:50 AM

NOSIUM AB (publ) offentliggör delårsrapport för perioden juli–september 2025

NOSIUM
Press release11/20/2025, 1:07 PM

NOSIUM PRESENTERAR MEDICORTEX

NOSIUM
Regulatory press release11/17/2025, 8:25 PM

NOSIUM signerar SPA med Medicortex – avser förvärva upp till 89,9 % till en premie om 233 % à 11,00 SEK/aktie i NOSIUM

NOSIUM
Regulatory press release10/28/2025, 9:30 AM

NOSIUM AB (publ) stärker sin position i Co-Properties AB genom aktiebyte med Equity Dynamics AB

NOSIUM
Regulatory press release10/24/2025, 11:00 AM

NOSIUM AB (publ) inleder förhandlingar om slutgiltigt förvärvsavtal med Medicortex Finland Oyj

NOSIUM